Company Filing History:
5 out of 26 
2 out of 1,866 
1 out of 8 Years Active: 2009-2024
Title: Innovations in Cancer Detection: The Contributions of Brian Brummeler Haab
Introduction
Brian Brummeler Haab is an accomplished inventor based in Jenison, Michigan. He has made significant contributions to the field of cancer research, particularly in the detection and treatment of pancreatic cancer. With a total of six patents to his name, Haab's work is at the forefront of medical innovation.
Latest Patents
Haab's latest patents focus on methods for detecting and treating pancreatic cancer. One notable patent describes a method of diagnosing pancreatic cancer by detecting levels of specific glycoforms of a Lewis antigen and MUC5AC. This innovative approach allows for early diagnosis, which is crucial for effective treatment. Additionally, he has developed a method for detecting glycan levels in biological samples, which involves using capture reagents to immobilize glycans on substrates and employing detection reagents to measure their levels. These advancements represent a significant step forward in the fight against pancreatic cancer.
Career Highlights
Throughout his career, Brian Brummeler Haab has worked with prestigious institutions such as the Van Andel Research Institute and the University of Pittsburgh. His experience in these research environments has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Haab has collaborated with notable colleagues, including Randall E. Brand and David M. Kruithoff. These partnerships have enhanced his research efforts and expanded the impact of his innovations in cancer detection.
Conclusion
Brian Brummeler Haab's contributions to the field of cancer research through his innovative patents are paving the way for improved diagnostic methods and treatments for pancreatic cancer. His work exemplifies the importance of innovation in the medical field and its potential to save lives.